Serum Institute's Covovax approved for kids aged 7 to 11 years


1 min read
Read later
Print
Share

Representative image | Photo: ANI

New Delhi: India's apex drugs regulator, the Drugs Controller General of India (DCGI), on Tuesday approved Pune-based Serum Institute's Covid vaccine Covovax for children aged 7 to 11 years, as per a source.

The source said that SII's Covovax vaccine has been approved for restricted emergency use in children aged 7 to 11 years subject with certain conditions.

On June 24, the DCGI's Subject Expert Committee had recommended emergency use authorisation to Covovax vaccine for use in children aged 7-11.

As per the source, the DCGI has also approved India's first indigenously developed mRNA vaccine against Covid-19 manufactured by Gennova Biopharmaceuticals for restricted emergency use for those aged 18 years and above.

The DCGI had approved Covovax for restricted use in emergency situations in adults on December 28 and in the 12 to 17 years age group, subject to certain conditions, on March 9.

(IANS)

Add Comment
Related Topics

Get daily updates from Mathrubhumi.com

Newsletter
Youtube
Telegram
Disclaimer: Kindly avoid objectionable, derogatory, unlawful and lewd comments, while responding to reports. Such comments are punishable under cyber laws. Please keep away from personal attacks. The opinions expressed here are the personal opinions of readers and not that of Mathrubhumi.

IN CASE YOU MISSED IT
Representative Image | Photo: Canva

5 min

India's elderly population expanding at an unprecedented rate: UNFPA; sheds light on wealth quintile

Sep 27, 2023


https://twitter.com/ani_digital

1 min

NIA raids 51 locations in 6 states, detains associate of Canada-based ‘terrorist’ Arsh Dalla

Sep 27, 2023


Security personnel stand guard during a protest rally by school students against the killing of two Meitei youths by suspected Kuki Zo militants, at Moirangkhom in Imphal West district | Photo: PTI

1 min

Evening Brief | 27 September 2023

Sep 27, 2023